AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Targeting the DDB1-CUL4A Ubiquitin Ligase for Cancer Prevention and Intervention

Detailed Technology Description
This invention teaches an approach and provides examples of agents that can prolong the activities of the NER (Nucleotide excision repair) enzyme, and therefore, enhance the cellular ability to repair DNA damages caused by environmental carcinogens and oxidation stress. This invention may find a wide range of applications in skin care and in conditions that benefit from the enhancement of DNA repair including cancer prevention and treatment. A method for screening for such agents is also taught.
Others
None
*Abstract

Nucleotide excision repair (NER) is the cellular mechanism to remove damaged DNA (e.g. DNA adducts) caused by exposure to carcinogens (e.g. radiation and chemicals) and oxidative stress. Research at Weill Cornell Medical College discovered that the inhibition of a novel negative regulator of NER prolongs and enhances DNA repair activities in vivo. Skin-specific knockout of a gene that is a key component of this novel negative regulator in mice demonstrated drastically improved resistance to skin cancer development caused by UV or chemical carcinogens. The knockout mice otherwise are normal (See figure). This novel negative regulator of NER and its inhibition present a new technology platform to develop products, consumer and clinical, for conditions that may benefit from prolonged and enhanced DNA repair activities. These may include skin care, anti-cancer and other health-related products. The researchers have identified siRNA and small protein inhibitors that significantly enhances cellular nucleotide excision repair activity. The development of small molecule inhibitors is currently in progress.

 

Potential Application

DNA repair enhancing agents are product candidates to:

  • delay skin aging in skin care products (DNA adducts caused by radiation)
  • prevent and treat cancers (esp. skin, lung, liver)
  • heart and vascular diseases (smoking-induced DNA adducts)
  • neurologic disorders related to DNA damage caused by oxidative stress and certain toxins

 

Advantages

  • The first down-regulator for NER enzyme
  • No need to repeatedly cover our body with chemical shield
  • One active ingredient provides protection for UVA, UVB, and chemical carcinogens
  • Can be incorporated into wide range skin care products
  • The first non-nicotine lung cancer prevention product
*Licensing
Dan-Oscar Antsonda429@cornell.edu212-746-1297
Country/Region
USA

For more information, please click Here
Mobile Device